Program
The Scientific Program will focus on evidence, policy and practice and comprises the following:
- Keynote presentations from National and International invited speakers
- Symposia on selected topics
- Concurrent oral sessions
- Poster sessions
- Clinical workshops/master classes
- Social functions
- Satellite meetings and launches
Keynote Speakers
Poster Sessions
Poster Session 1
Monday, 24 November 2008 - 12:00 - 12:45, Monday
Poster Session 2
Tuesday, 25 November 2008 - 12:00 12:45, Tuesday
Satellite Meetings and Launches
Launch - 13:30, Monday, Drugs and Public Health: Australian Perspectives on Policy and Practice
Launch - 13:30, Monday, Bridging the Divide
Launch - 13:30, Tuesday, Handbook in Addiction Medicine
Launch - 13:00, Wednesday, NUUA Website
Workshops and Symposia
a. Psychostimulant Interventions Workshop - 13:45 - 15:30, Monday
b. Mental Health Emergencies Workshop - 16:00 - 17:30, Monday
c. Cannabis Brief Interventions Workshop - 16:00 - 17:30, Monday
d. Aboriginal and Torres Strait Islander Issues Symposium - 16:00 - 17:30, Monday
e. Indigenous Risk Screening and Intervention Workshop - 13:45 - 15:30, Tuesday
f. Drug Law Enforcement Symposium - 13:45 - 15:30, Tuesday
g. Smoking Cessation Workshop - 16:00 - 17:30, Tuesday
h. Stepping Stones Program Workshop - 16:00 - 17:30, Tuesday
i. Consumer Participation Workshop - 11:00 - 12:20, Wednesday
j. SMART Recovery Workshop - 11:00 - 12:20, Wednesday
k. Personality and Drug Use Symposium - 11:00 - 12:20, Wednesday
l. Hepatitis C -13:15 - 14:35, Wednesday
Sunday's Workshops:
a. NET Double Trouble Forum - 09:00 - 17:30
b. National Drug Trends Conference - 09:00 - 17:30
c. Reckitt Benckiser Symposium - 13:00 - 17:30
:
Date: Sunday, 23 November 2008 (One day Workshop) $275 Registration required
Venue: Bayside 105 & Reckitt Benkiser Symposium to 104, Sydney Convention and Exhibition Centre
Time: 09:00 - 17:30
Comorbidity between drug and alcohol and mental health continues to be one of the greatest challenges facing our treatment services. Mental health and drug and alcohol services are struggling to find adequate resources and effective treatments.
Australia is at the forefront of both acknowledging and responding to comorbidity.
This one-day forum brings together experts to interactively discuss the latest challenges and responses to these issues. The speakers will focus on the latest research, updates on drug use trends, updates on best practice in service provision, new treatments, perspectives on how national and local policies and strategies can make a difference,
The program will be of particular interest to policy makers, clinicians, and researchers. You will receive many useful ideas to improve your service for this target group, places are limited!
On the day we will focus on:
a. The latest drug trends,
b. Managing amphetamine psychosis,
c. Treatments for anxiety and alcohol disorders
The day includes opportunities for in-depth discussion and exchange of experiences.
08.45-09.00
COFFEE/TEA on ARRIVAL
09.00-09.10
Chair:Maree Teesson
Speaker:Shirley Gilbert
Topic:Welcome to country
09.10-09.30
Speaker:Maree Teesson
TopicOverview
09.30-10.30
Speaker:George Patton
Topic:Comorbidity & young people
10.30-11.00
MORNING TEA
11.00-11.45
Chair:Adam Winstock
Speaker:Andrew Bailie
TopicSocial phobia
11.45-12.30
Presenter:Amanda Baker
Topic:Alcohol & depression
12.30-13.30
LUNCH
13.30-14.15
Chair:Amanda Baker
Presenter:Glenys Dore
TopicManaging Methamphetamine Madness, Mayhem and Mood Disturbance
14.15-15.00
Presenter:Kath Mills
Topic:PTSD
15.00-16.00
Presenter:Adam Winstock
Topic: Pitfalls of preciptious diagnosis
Reckitt Benckiser Symposium - Future Treatment Directions
This interactive symposium features both international and national addiction experts exploring current and future treatment directions, prescription opiate misuse and other topical issues facing doctors, healthcare workers and patients.
Date: Sunday 23rd November
Time: 13:00 - 17:00 (registration 12:30pm)
Venue: Level 1, Bayside 105, Sydney Convention & Exhibition Centre
Cost: Free, Registration is essential
Chairperson
a. Associate Prof Jeremy Hayllar
b. Clinical Director of the Alcohol and Drug Service
c. Northside Health Service District, Brisbane
Presenters:
Associate Adrian Dunlop
Area Director of Drug & Alcohol Services
Hunter New England
Associate Prof Nick Lintzeris
Senior Staff Specialist
Sydney South West
Professor Eric Strain
Director of Substance Abuse Services
Johns Hopkins University School of Medicine
Prof Jason White
Head of Discipline of Pharmacology
Adelaide University
Video Interview
Associate Prof Mori Krantz
Director, Cardiac Risk Reduction Program
Denver Health & Hospitals
Expert Panel Discussion
RSVP
Kristel Benjamin
02 9325 4005
kristel.benjamin@reckittbenckiser.com
National Drug Trends Conference
Date: Sunday, 23 November 2008 (One day Workshop)
Cost: $180
Student Concession/drug user organisation representative: $115
Venue: Level 1, Bayside 103, Sydney Convention & Exhibition Centre
What's new in illicit drug use in Australia?
The National Drug Trends Conference will present recent findings in illicit drug use, markets and related harms across Australia. Convened by Australia's largest drug monitoring systems, the Illicit Drug Reporting System (IDRS) and the Ecstasy and Related Drugs Reporting System (EDRS), the one day conference will include the first release of the 2008 findings, in addition to discussion of emerging trends in illicit drug use and related issues in Australia.
We are also delighted to announce that there will also be presentations from three distinguished guest speakers, including Prof. Don Weatherburn (Australia), Mr Jeremy Douglas (Austria) and Dr David Caldicott (Australia).
Guest presentations will include:
a.Did the heroin shortage increase amphetamine use? A time series analysis - Prof. Don Weatherburn and Ms Lucy Snowball, NSW Bureau of Crime Statistics and Research
b. The global SMART programme: monitoring synthetic drug markets around the world - Mr Jeremy Douglas, UNODC Vienna
c. Monitoring illicit drug related harm: how to reach the data that social survey's can't- Dr David Caldicott, Royal Adelaide Hospital - Dr David Caldicott, Royal Adelaide Hospital IDRS and EDRS talks will include:
a. Key findings from the 2008 Illicit Drug Reporting System
b. Key findings from the 2008 Ecstasy and Related Drugs Reporting System
c. Is the use of khat an emerging practice among regular ecstasy users in Melbourne?
d. Getting the message: Where do people who inject drugs get information about safer drug use and health?
e. SA EDRS findings: Drug driving, bingeing, gambling and other risk taking behaviours
f. Comparing physical and mental health scores in the Sydney regular drug user surveys
For more information on the IDRS and EDRS visit the NDARC website
- Monitoring illicit drug related harm: how to reach the data that social survey's can't- Dr David Caldicott, Royal Adelaide Hospital – Dr David Caldicott, Royal Adelaide Hospital
IDRS and EDRS talks will include:
- Key findings from the 2008 Illicit Drug Reporting System
- Key findings from the 2008 Ecstasy and Related Drugs Reporting System
- Is the use of khat an emerging practice among regular ecstasy users in Melbourne?
- Getting the message: Where do people who inject drugs get information about safer drug use and health?
- SA EDRS findings: Drug driving, bingeing, gambling and other risk taking behaviours
- Comparing physical and mental health scores in the Sydney regular drug user surveys
For more information on the IDRS and EDRS visit the NDARC website
Dr Marina Davoli
Medical Doctor, Master of Science in Epidemiology, Director of the "Clinical Epidemiology Unit", Department of Epidemiology, Regional Referral Centre, Lazio, Italy
Co-ordinating Editor of the Cochrane Review Group on Drugs and Alcohol
Co-Chair of the Scientific Committee, European Monitoring Centre for Drugs and Drug Addiction
Experience in:
- epidemiological studies on prevalence and mortality of drug addicts
- systematic reviews of effectiveness of interventions for drug addiction
- management of the editorial process of systematic reviews for the Cochrane Library
- Teacher in University Master programmes of Epidemiology and Evidence Based Medicine
- Author and co-author of about 80 scientific publications
Associate Professor Greg Dore
Associate Professor Gregory Dore is Head of the Viral Hepatitis Clinical Research Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales and an Infectious Diseases Physician at St Vincent's Hospital, Sydney. He has been involved in the areas of viral hepatitis and HIV for many years, in academic research, clinical, and public health policy capacities.
Professor Dore's major research work has been in natural history and therapeutic strategies for acute and chronic hepatitis C. He is a NHMRC Practitioner Fellowship and has recently been awarded a NHMRC Program Grant.
Professor Ian Hickie
Professor Ian Hickie AM, MD, RANZCP, FASSA Executive Director, Brain & Mind Research Institute (BMRI), University of Sydney
In October 2006, the Australian Financial Review included Professor Hickie in its list of the top 10 cultural influences. The specific comments noted his role as a "long-term campaigner", "the person who orchestrated the campaign" that led to the COAG announcements ($4 billion dollars over five years) and congratulated him on "(his) depth of involvement and (his) huge contribution". From 1997 to 2003, Professor Hickie was Professor of Community Psychiatry at the University of NSW. In October 2000 he was appointed as the inaugural CEO of beyondblue: the national depression initiative and from 2003-06 served as its Clinical Advisor. In 2003, he was appointed as the inaugural executive director of the flagship Brain and Mind Research Institute at the University of Sydney. This institute leads innovation in research, clinical service and health policy developments in the Brain and Mind Sciences. It has attracted over $70 million in new investments in infrastructure in this key health domain. In 2006, Professor Hickie received the Australian Honours Award of Member (AM) in the General Division; for services to medicine in the development of key national mental health initiatives and general practice services in both the public and non-government sectors. In 2007, he was appointed to the Prime Minister's Australian National Council on Drugs and has led the BMRI as a founding member of the new National Youth Mental Health Foundation ('headspace'). From 2008-13, Professor Hickie is one of the first round of new NHMRC 2008 Australian Fellows; recognising excellence in Australian Medical Research. His research, clinical and health services development work focuses on expansion of population-based mental health research and development of international mental health strategies. In 2007, Professor Hickie was elected as a Fellow of the Academy of the Social Sciences in Australia.
Professor Ross Homel
Ross Homel is Foundation Professor of Criminology and Criminal Justice at Griffith University in Brisbane, Australia, and Director of the University's Strategic Research Program in the Social and Behavioural Sciences. From 2004 till 2007 he was Director of the Key Centre for Ethics, Law, Justice and Governance at Griffith, and he also served as Head of the School of Criminology and Criminal Justice between 1993 and 96 and in 2002 and 2003. He was editor of the Australian and New Zealand Journal of Criminology from 1992 to 1995, and was a part-time Commissioner of the Queensland Criminal Justice Commission from February 1994 to April 1999.
In 2004 he was elected a Fellow of the Academy of the Social Sciences in Australia, and in 2006 was appointed to the Board of the Council for the Humanities, Arts and Social Sciences. In January 2008 was appointed an Officer in the General Division of the Order of Australia (AO). The AO was for "For service to education, particularly in the field of criminology, through research into the causes of crime, early intervention and prevention methods."
Dr Rosalie Pacula
Rosalie Liccardo Pacula is a Senior Economist and the Co-Director of RAND's Drug Policy Research Center. Dr. Pacula's research to date has largely focused on evaluating the effectiveness and cost-effectiveness of federal, state and local public policies at diminishing youth substance use and abuse as well as their social costs. Ongoing research areas include developing new methods for estimating the social cost of drug abuse; modeling the impact of enforcement and policy on drug markets; and assessing the cost-benefit of drug treatment and prevention programs. Dr. Pacula is currently an Assistant Editor for Addiction.
Professor Robin Room
Robin Room is an Australian sociologist who worked for many years abroad in alcohol and drug studies in the U.S., Canada, Norway and Sweden. Since 2006, he has been a Professor in the School of Population Health of the University of Melbourne and the Director of the AER Centre for Alcohol Policy Research at Turning Point Alcohol and Drug Centre. He has worked on social, cultural and epidemiological studies of alcohol, drugs and gambling behaviour and problems, and studies of social responses to alcohol and drug problems and of the effects of policy changes.
Professor Rob Sanson-Fisher
Rob Sanson-Fisher is laureate Professor at the University of Newcastle medical school. He has published extensively in the field of alcohol, chaired the NHMRC's expert advisory group on the topic and is currently working with colleagues on a large-scale randomised controlled trial designed to reduce alcohol-related harm in 10 rural communities. He undertaken studies examining the quality of care associated with drug and alcohol services is well as strategies designed to increase the evidence base for treatment in this area. He continues to develop, implement and evaluate attempts to reduce the evidence practice gap.
Associate Professor Mark Tyndall
Dr. Mark Tyndall is an Associate Professor at the University of British Columbia, and Head of Infectious Diseases at Providence Health Care. He received his MD degree from McMaster University and a Doctoral Degree in Epidemiology from Harvard University focusing on HIV transmission in Kenya. He is currently an investigator on a number of projects in Vancouver, including epidemiologic studies of HIV and Hepatitis C transmission, antiretroviral access and adherence among injection drug users, and the evaluation of the supervised injection facility. He is an author on over 140 peer-reviewed publications, and holds a Michael Smith Foundation for Health Research Senior Scholar Award.